Cigarette smoking and cognitive impairment: A 10-year cohort study in Taiwan

Archives of Gerontology and Geriatrics

Volumn 51, Issue 2, 2010, Pages 143-148

  Wang, Cheng Ching ^a,b   Lu, Tsung Hsueh ^c   Liao, Wen Chun ^a,b   Yuan, Su Chuan ^a,b   Kuo, Pi Chao ^a,b   Chuang, Hsiao Ling ^a   Lee, Meng Chih ^a,b,d   Yen, Chi Hua ^a,b,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b Center for Education and Research on Geriatrics and Gerontology (CEROGG)   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cigarette smoking; Cognitive impairment; Cohort study in Taiwan

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CIGARETTE SMOKING; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; EDUCATION; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; POPULATION RESEARCH; PRIORITY JOURNAL; SHORT PORTABLE MENTAL STATUS QUESTIONNAIRE; SMOKING CESSATION; STROKE; TAIWAN;

EID: 77955275496     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2009.09.041     Document Type: Article

References (43)

1. Almeida O.P., Hulse G.K., Lawrence D., Flicker L. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 2001, 97:15-28.
2. Anstey K.J., Von Sanden C., Salim A., O'Kearney R. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol. 2007, 166:367-378.
3. Apple S. Alzheimer's disease. Brain Neurotransmitters and Receptors in Aging and Age-Related Disorders 1981, 203-207. Raven Press, New York, NY. S. Enna (Ed.).
4. Cervilla J.A., Prince M., Mann A. Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J. Neurol. Neurosurg. Psychiatry 2000, 68:622-626.
5. Cheng S.H., Chiang T.L. The effect of universal health insurance on health care utilization in Taiwan: results from a natural experiment. J. Am. Med. Assoc. 1997, 278:89-93.
6. Chi I., Boey K.W. Validation of Measuring Instruments of Mental Health Status of the Elderly in Hong Kong 1992, Department of Social Work and Administration, University of Hong Kong, Hong Kong.
7. Chiang T.L. Taiwan's 1995 health care reform. Health Policy 1997, 39:225-239.
8. Corrada M.M., Brookmeyer R., Berlau D., Paganini-Hill A., Kawas C.H. Prevalence of dementia after age 90: results from the 90+ study. Neurology 2008, 71:337-343.
9. Cruickshank J.M., Neil-Dwyer G., Dorrance D.E., Hayes Y., Patel S. Acute effects of smoking on blood pressure and cerebral blood flow. J. Hum. Hypertens. 1989, 3:443-449.
10. Doll R., Peto R., Boreham J., Sutherland I. Smoking and dementia in male British doctors: prospective study. Br. Med. J. 2000, 320:1097-1102.
11. Euser S.M., Schram M.T., Hofman A., Westendorp R.G.J., Breteler M.M.B. Measuring cognitive function with age: the influence of selection by health and survival. Epidemiology 2008, 19:440-447.
12. Fillenbaum G.G., Smyer M.A. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J. Gerontol. 1981, 36:428-434.
13. Grossberg G.T., Nakra R., Woodward V., Russell T. Smoking as a risk factor for Alzheimer's disease. J. Am. Geriatr. Soc. 1989, 37:819.
14. Hedden T., Gabrieli J.D. Insight into the ageing mind: a view from cognitive neuroscience. Nat. Rev. Neurosci. 2004, 5:87-96.
15. Hill R.D., Seelert K.S. Cigarette Smoking and Cognitive Function. Cognitive Rehabilitation in Old Age 2000, Oxford University Press, New York, NY.
16. Hill R.D., Nilsson L.G., Nyberg L., Bäckman L. Cigarette smoking and cognitive performance in healthy Swedish adults. Age Ageing 2003, 32:548-550.
17. Hofman A., van Duijn C.M. Alzheimer's disease, Parkinson's disease, and smoking, (Abstract). Neurobiol. Aging 1990, 11:295.
18. Hsu H.C. Does social participation by the elderly reduce mortality and cognitive impairment?. Aging Ment. Health 2007, 11:699-707.
19. Ikeda A., Yamagishi K., Tanigawa T., Cui R., Yao M., Noda H., Umesawa M., Chei C., Yokota K., Shiina Y., Harada M., Murata K., Asada T., Shimamoto T., Iso H. Cigarette smoking and risk of disabling dementia in a Japanese rural community: a nested case-control study. Cerebrovasc. Dis. 2007, 25:324-331.
20. Jones G.M., Sahakian B.J., Levy R., Warburton D.M., Gray J.A. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl.) 1992, 108:485-494.
21. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology (Berl.) 1992, 108:417-431.
22. Levin E.D., Rezvani A.H. Development of nicotine drug therapy for cognitive disorders. Eur. J. Pharmacol. 2000, 393:141-146.
23. Levin E.D., McClernon F.J., Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl.) 2006, 184:523-539.
24. Merchant C., Tang M.X., Albert S., Manly J., Stern Y., Mayeux R. The influence of smoking on the risk of Alzheimer's disease. Neurology 1999, 52:1408-1412.
25. Newhouse P.A., Potter A., Singh A. Effects of nicotinic stimulation on cognitive performance. Curr. Opin. Pharmacol. 2004, 4:36-46.
26. Ofstedal M.B., Zimmer Z.S., Lin H.S. A comparison of correlates of cognitive functioning in older persons in Taiwan and the United States. J. Gerontol. B: Psychol. Sci. Soc. Sci. 1999, 54:S291-S301.
27. Ott A., Anderson K., Dewey M.E., Letenneur L., Brayne C., Copeland J.R., Dartigues J.F., Kragh-Sorensen P., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A., Launer L.J. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004, 62:920-924. EURODEM Incidence Research Group.
28. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 1975, 23:433-441.
29. Pincheira J., Gallo C., Bravo M., Navarrete M.H., Lopez-Saez J.F. G2 repair and aging: influence of donor age on chromosomal aberrations in human lymphocytes. Mutat. Res. 1993, 295:55-62.
30. Purser J.L., Fillenbaum G.G., Pieper C.F., Wallace R.B. Mild cognitive impairment and 10-year trajectories of disability in the Iowa Established Populations for Epidemiological Studies of the Elderly cohort. J. Am. Geriatr. Soc. 2005, 53:1966-1972.
31. Reitz C., Heijer T.D., Van Duijn C.M., Hofman A., Breteler M.M. Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology 2007, 69:998-1005.
32. Rezvani A.H., Levin E.D. Cognitive effects of nicotine. Biol. Psychiatry 2001, 49:258-267.
33. Richards M., Jarvis M.J., Thompson N., Wadsworth M.E. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am. J. Public Health 2003, 93:994-998.
34. Swan G.E., Lessov-Schlaggar N.L. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol. Rev. 2007, 17:259-273.
35. Taylor D.H., Schenkman M., Zhou J., Sloan F.A. The relative effect of Alzheimer's disease and related dementias, disability, and comorbidities on cost of care for elderly persons. J. Gerontol. B: Psychol. Sci. Soc. Sci. 2001, 56:S285-S293.
36. Tyas S.L. Are tobacco and alcohol use related to Alzheimer's disease? A critical assessment of the evidence and its implications. Addict. Biol. 1996, 1:237-254.
37. Tyas S.L., White L.R., Petrovitch H., Webster Ross G., Foley D.J., Heimovitz H.K., Launer L.J. Mid-life smoking and late-life dementia: the Honolulu-Asia aging study. Neurobiol. Aging 2003, 24:589-596.
38. Van Duijn C.M., Hofman A. Risk factors for Alzheimer's disease: the EURODEM collaborative re-analysis of case-control studies. Neuroepidemiology 1992, 11(Suppl. 1):S106-S112.
39. Warburton D.M., Arnall C. Improvements in performance without nicotine withdrawal. Psychopharmacology (Berl.) 1994, 115:539-542.
40. Yen L.L., Pam L.Y. Smoking prevalence and behaviors of adults in Taiwan: a national survey, 1999. Chin. J. Public Health 2000, 19:423-436.
41. Yen Y.C., Rebok G.W., Yang M.J., Lung F.W. A multilevel analysis of the influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated by the environment. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:479-486.
42. Yong H.H., Borland R., Siahpush M. Quitting-related beliefs, intentions, and motivations of older smokers in four countries: findings from the International Tobacco Control Policy Evaluation Survey. Addict. Behav. 2005, 30:777-788.
43. Zimmer Z., Martin L.G., Chang M.C. Changes in functional limitation and survival among older Taiwanese, 1993, 1996, and 1999. Popul. Stud. (Camb.) 2002, 56:265-276.